| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 323 | 388 | 0 | 0 | 74 | 62 | 40 | 61 | 40 | 63 |
| Gross Profit/Loss - EUR | -323 | -388 | 0 | 0 | -74 | -62 | -40 | -61 | -40 | -63 |
| Net Profit/Loss - EUR | -323 | -388 | 0 | 0 | -74 | -62 | -40 | -61 | -40 | -63 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Neuromed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.707 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 3.058 | 3.083 | 3.031 | 2.975 | 2.918 | 2.862 | 2.799 | 2.808 | 2.799 | 2.784 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 257 | 253 | 248 | 243 | 239 | 233 | 234 | 233 | 232 |
| Cash | 3.058 | 2.826 | 2.778 | 2.727 | 2.674 | 2.624 | 2.565 | 2.573 | 2.566 | 2.551 |
| Shareholders Funds | 3.751 | 3.325 | 3.269 | 3.209 | 3.073 | 2.953 | 2.847 | 2.795 | 2.746 | 2.668 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.613 | 1.689 | 1.660 | 1.630 | 1.672 | 1.702 | 1.705 | 1.771 | 1.806 | 1.859 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuromed Srl